Should We Synthesize A Human Genome?
By Drew Endy and Laurie Zoloth,
DSpace@MIT
| 05. 10. 2016
At Harvard today an invitation-only group of mostly scientists, lawyers, and entrepreneurs, ~150 in total, met to discuss if and how to synthesize from scratch an entire human genome – the heritable genetic material that in nature is transferred from parents to children. The meeting was originally organized to focus on “deliverables and industry involvement” with the primary goal of the project being “to synthesize a complete human genome in a cell line within a period of ten years.”
Synthesis refers to the construction of a genome starting from simple chemicals. Such a synthetic genome could then be tested in a laboratory by replacing the existing genome within a human cell. All this would still be far removed from making a synthetic human. However, the possibility of making a human cell whose genome is realized from only digital information and raw materials should trigger broader considerations.
...
Returning to our primary question, just because something becomes possible, how should we determine if it is ethical to proceed?
Continue reading at DSpace@MIT...
Image via Flikr/University of Michigan School of Natural...
Related Articles
By Rob Stein, NPR [cites CGS' Katie Hasson] | 08.06.2025
A Chinese scientist horrified the world in 2018 when he revealed he had secretly engineered the birth of the world's first gene-edited babies.
His work was reviled as reckless and unethical because, among other reasons, gene-editing was so new...
By Susanna Smith, Genetic Frontiers | 07.28.2025
Key Topics
How does the American far right view genetics and genetic technologies?
What is the history of the American cultural pursuit of trying to choose smarter children? What has science shown us about the relationship of heredity and intelligence...
By Arthur Caplan and James Tabery, Scientific American | 07.28.2025
An understandable ethics outcry greeted the June announcement of a software platform that offers aspiring parents “genetic optimization” of their embryos. Touted by Nucleus Genomics’ CEO Kian Sadeghi, the $5,999 service, dubbed “Nucleus Embryo,” promised optimization of...
By John H. Evans, Craig Callender, Neal K. Devaraj, Farren J. Isaacs, and Gregory E. Kaebnick, Issues in Science and Technology | 07.04.2025
The controversy around a ban on “mirror life” should lead to a more nuanced public conversation about how to manage the benefits and risks of precursor biotechnologies.
About five years ago, the five of us formed a discussion group to...